IL17A and rheumatoid arthritis: Interestingly, while the cytokine treatment-induced IL-17A production was profoundly different between RA and PsA as compared to healthy donors, the IL-22 production was different between RA and healthy donors, but not between healthy donors and PsA patients (Figure S5 in Supplementary Material).